The world’s only authorized monkeypox vaccine, Bavarian Nordic’s Jynneos vaccine, is set to be split into fifths after the FDA cleared the strategy on Aug. 9 — a solution that could indicate the future for resolving emergency drug shortages, pharmacy and supply chain experts said.
Read the full post on Becker's Hospital Review - Healthcare News
